NMDP BioTherapies

NMDP BioTherapies is the only provider of customizable cell and gene therapy solutions to support end-to-end cell therapy supply chains. Backed by NMDP’s industry-leading experience and a research partnership with CIBMTR® (Center for International Blood and Marrow Transplant Research®), the organization designs solutions that drive the advancement of global cell and gene therapies.NMDP BioTherapies is committed to accelerating patient access to life-saving cell and gene therapies by providing high-quality source material from the NMDP registry, the most diverse registry in the world with over 7 million potential hematopoietic stem cell donors. By building relationships with apheresis, bone marrow collection, and transplant centers worldwide, the organization develops, recruits, trains, and manages an extensive collection network to advance cell therapies. NMDP BioTherapies leverages proven infrastructure, including compliance and logistics management experts as well as cell therapy supply chain case managers, to successfully transport and deliver regulatory-compliant life-saving therapies globally. Through CIBMTR, NMDP extends its services beyond the cell therapy supply chain to include long-term follow-up tracking for FDA-approved CAR-T therapies.